Datasets
Buyer room
EVERNORTH.COMManage supplier listing
Evernorth Clinical Trial Solutions (Evernorth Health Services) — Population-scale medical and prescription (pharmacy dispense) records joined to demographic and geographic attributes across a U.S. commercial insured population, used to build protocol-eligible cohorts and to run direct-to-patient recruitment. The asset is not merely the cohort: it is the closed-loop record linking an algorithmic eligibility prediction to the observed response and screening outcome for each contacted patient — reach, call-to-action response, CRO pre-screen result, and screening pass — at national geographic cov…
supplier index read from their site
Population-scale medical and prescription (pharmacy dispense) records joined to demographic and geographic attributes across a U.S. commercial insured population, used to build protocol-eligible cohorts and to run direct-to-patient recruitment. The asset is not merely the cohort: it is the closed-loop record linking an algorithmic eligibility prediction to the observed response and screening outcome for each contacted patient — reach, call-to-action response, CRO pre-screen result, and screening pass — at national geographic coverage.
From 20 yearsAsset class EquitiesTickers MRK · PFE · LLY
Sample, licence terms, pricing and eval results when Evernorth publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Evernorth, answered from this page.
Evernorth Clinical Trial Solutions (Evernorth Health Services) — Population-scale medical and prescription (pharmacy dispense) records joined to demographic and geographic attributes across a U.S. commercial insured population, used to build protocol-eligible cohorts and to run direct-to-patient recruitment. The asset is not merely the cohort: it is the closed-loop record linking an algorithmic eligibility prediction to the observed response and screening outcome for each contacted patient — reach, call-to-action response, CRO pre-screen result, and screening pass — at national geographic cov…
Evernorth offers (Alternative, Fundamental, Sentiment) — Not printed. Order-of-magnitude estimate: a national commercial medical-plus-prescription network at this enterprise scale implies 10^10+ claim lines and a comparable volume of pharmacy dispense records annually, each longitudinally linked to the same member. Only the documented pilot is quantified: 6,700 contacted patients, 378 responders, 160 screening passes in one breast-cancer programme..
Training eligibility/feasibility algorithms on claims features validated against real screening verdicts (rare — most RWD has no trial-outcome linkage); patient-recruitment response-propensity models (which messaging/channel/sequence converts eligible patients); trial diversity and representativeness modelling against U.S. population benchmarks by state (directly serves regulator diversity expectations); epidemiological prevalence and treatment-pathway studies from medical plus pharmacy records; enrollment-timeline and cost forecasting; health-services research on access to clinical research.
The data is with 20 years of history.
Coverage spans US; Health Care Technology, Life Sciences Tools & Services; alternative, fundamental, sentiment; equities.
Evernorth has not added their own details yet. Not yet on file: